Mobile team vs. lab: which HPV screening strategy works best for women with HIV?

NCT ID NCT07181278

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two ways to screen for cervical cancer in women with HIV in Cameroon. One way sends self-collected samples to a central lab; the other uses a mobile team that tests and treats on the spot. Researchers want to see which approach helps more women complete all screening steps. About 1,180 women aged 25 to 49 will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that a mobile team offering same-day HPV testing and treatment is more effective than sending samples to a central lab, helping more women complete screening.
What could go wrong
This is an observational study comparing two existing strategies, not testing a new treatment. Results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bafoussam Baptist Hospital

    RECRUITING

    Bafoussam, Cameroon

  • Bandjoun District Hospital

    RECRUITING

    Bandjoun, Cameroon

  • Bingo Hospital

    RECRUITING

    Bafoussam, Cameroon

  • Centre Médical Spécialisé ACHA

    RECRUITING

    Bafoussam, Cameroon

  • Foumbot District Hospital

    RECRUITING

    Foumbot, Cameroon

  • Hôpital Régional Annexe

    RECRUITING

    Bafoussam, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.